Found: 21
Select item for more details and to access through your institution.
Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 468, doi. 10.1007/s10637-018-0583-z
- By:
- Publication type:
- Article
Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 729, doi. 10.1007/s10637-010-9561-9
- By:
- Publication type:
- Article
Expanding the molecular landscape of undifferentiated sarcomas of bone with a novel EWSR1‐SSX3 gene fusion.
- Published in:
- Genes, Chromosomes & Cancer, 2024, v. 63, n. 1, p. 1, doi. 10.1002/gcc.23215
- By:
- Publication type:
- Article
Salvage surgical resection after high‐dose ifosfamide (HDIF) based regimens in advanced soft tissue sarcoma (ASTS): A potential positive selection bias—A study of the Spanish Group for Research on Sarcomas (GEIS)Presented in part at the Thirty‐Eighth Annual Meeting of the American Society of Clinical Oncology, Orlando, May 18–21, 2002.
- Published in:
- Journal of Surgical Oncology, 2004, v. 88, n. 1, p. 44, doi. 10.1002/jso.20131
- By:
- Publication type:
- Article
2023 GEIS Guidelines for gastrointestinal stromal tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, v. 15, p. 1, doi. 10.1177/17588359231192388
- By:
- Publication type:
- Article
Single-Center Experience with Trabectedin for the Treatment of Non-L-sarcomas.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 4, p. 1596, doi. 10.1007/s12325-022-02051-2
- By:
- Publication type:
- Article
Histologically negative specimens after induction therapy: Frequency and impact on survival.
- Published in:
- Head & Neck, 2000, v. 22, n. 8, p. 808, doi. 10.1002/1097-0347(200012)22:8<808::AID-HED10>3.0.CO;2-1
- By:
- Publication type:
- Article
Second neoplasm in patients with head and neck cancer.
- Published in:
- Head & Neck, 1999, v. 21, n. 3, p. 204, doi. 10.1002/(SICI)1097-0347(199905)21:3<204::AID-HED4>3.0.CO;2-7
- By:
- Publication type:
- Article
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 11, p. 1195, doi. 10.3390/diagnostics14111195
- By:
- Publication type:
- Article
Optimization of the Therapeutic Approach to Patients with Sarcoma: Delphi Consensus.
- Published in:
- Sarcoma, 2019, p. 1, doi. 10.1155/2019/4351308
- By:
- Publication type:
- Article
Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2005, v. 262, n. 2, p. 93, doi. 10.1007/s00405-004-0749-5
- By:
- Publication type:
- Article
Effect of serpinE1 overexpression on the primary tumor and lymph node, and lung metastases in head and neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2019, v. 41, n. 2, p. 429, doi. 10.1002/hed.25437
- By:
- Publication type:
- Article
CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma.
- Published in:
- Head & Neck, 2016, v. 38, p. E1392, doi. 10.1002/hed.24232
- By:
- Publication type:
- Article
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib.
- Published in:
- Cancers, 2022, v. 14, n. 17, p. 4186, doi. 10.3390/cancers14174186
- By:
- Publication type:
- Article
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 792, doi. 10.3390/cancers13040792
- By:
- Publication type:
- Article
Evidence mapping based on systematic reviews of therapeutic interventions for gastrointestinal stromal tumors (GIST).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 4, p. 618, doi. 10.3390/jpm12040618
- By:
- Publication type:
- Article
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase II Study of Gemcitabine Plus Sirolimus in Previously Treated Patients with Advanced Soft-Tissue Sarcoma: a Spanish Group for Research on Sarcomas (GEIS) Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study).
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 4, p. 254, doi. 10.1007/s12094-011-0650-9
- By:
- Publication type:
- Article
Sequential dose-dense doxorubicin and ifosfamide for advanced soft tissue sarcomas.
- Published in:
- Cancer (0008543X), 2004, v. 100, n. 7, p. 1498
- By:
- Publication type:
- Article